Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XYLO
XYLO logo

XYLO Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
-1.71M
EV/OCF(TTM)
--
P/S(TTM)
1.93
Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
Show More

Events Timeline

(ET)
2025-12-01
08:50:00
SciSparc Acquires 19.99% Stake in Xylo's Patent Portfolio for Innovative Medical Systems
select
2025-06-05 (ET)
2025-06-05
09:25:38
Xylo Technologies says Viewbix shares to begin trading on Nasdaq
select
2025-04-30 (ET)
2025-04-30
09:21:46
Xylo announces Charging Robotics installed system for wireless charging
select
2025-04-10 (ET)
2025-04-10
09:27:26
Xylo Technologies announces Revoltz launches commercial phase of PORTO EV
select

News

Newsfilter
8.5
2025-06-05Newsfilter
Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq
  • Viewbix Inc. Listing: Viewbix Inc., a digital advertising technology developer, has received approval to list its shares on the Nasdaq Capital Market under the symbol "VBIX," with trading expected to commence on June 5, 2025. Xylo Technologies Ltd. holds a significant indirect stake in Viewbix through its ownership in Gix Internet.

  • Xylo Technologies Overview: Xylo Technologies is an Israeli company focused on innovative partnerships in various sectors, including advanced medical solutions, digital commerce, and electric vehicles, and it supports Viewbix's growth through its investment in Gix Internet.

Newsfilter
6.5
2024-08-15Newsfilter
Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems
  • Partnership Announcement: Xylo Technologies' affiliate, ParaZero Technologies, has partnered with a Tier 1 defense OEM to adapt its drone safety systems for military and medical missions, starting with an initial order of 50 systems for testing.

  • Future Plans: Upon successful testing, the customer intends to order hundreds more systems for a pilot program, aiming for scalable production to enhance medical delivery efficiency and safety in critical areas by the end of 2024.

Wall Street analysts forecast XYLO stock price to rise
1 Analyst Rating
Wall Street analysts forecast XYLO stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
5.00
Averages
5.00
High
5.00
Current: 0.000
sliders
Low
5.00
Averages
5.00
High
5.00
No data

No data

Valuation Metrics

The current forward P/E ratio for Xylo Technologies Ltd (XYLO.O) is 0.84, compared to its 5-year average forward P/E of -7.05. For a more detailed relative valuation and DCF analysis to assess Xylo Technologies Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-7.05
Current PE
0.84
Overvalued PE
21.39
Undervalued PE
-35.49

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.20
Current PS
0.03
Overvalued PS
3.68
Undervalued PS
-1.28

Financials

AI Analysis
Annual
Quarterly

Whales Holding XYLO

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Xylo Technologies Ltd (XYLO) stock price today?

The current price of XYLO is 0 USD — it has increased 0

What is Xylo Technologies Ltd (XYLO)'s business?

Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).

What is the price predicton of XYLO Stock?

Wall Street analysts forecast XYLO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XYLO is5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Xylo Technologies Ltd (XYLO)'s revenue for the last quarter?

Xylo Technologies Ltd revenue for the last quarter amounts to NaN USD, decreased

What is Xylo Technologies Ltd (XYLO)'s earnings per share (EPS) for the last quarter?

Xylo Technologies Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Xylo Technologies Ltd (XYLO). have?

Xylo Technologies Ltd (XYLO) has 38 emplpoyees as of May 15 2026.

What is Xylo Technologies Ltd (XYLO) market cap?

Today XYLO has the market capitalization of 0.00 USD.